() -Several pharmaceutical companies have said they will sell drugs direct to patients in the U. and offered discounts ...
Several pharmaceutical companies have said they will sell drugs direct to patients in the U.S. and offered discounts ...
StubHub Holdings (NASDAQ: STUB) is expected to grow revenue through its dominant market share, new initiatives, and ad ...
First deals impact Medicaid but drug makers hint they may sell all of their new drugs at most-favored-nation pricing.
AstraZeneca has become the second pharma group, after Pfizer, to reach an agreement with the Trump administration on a deal ...
Read our in-depth H&R Block review covering pricing, features, and pros & cons to help you decide if it's the right tax ...
Developments announced the pricing of a registered direct offering in the United States priced at-the-market in accordance with the ...
StubHub shares rose nearly 6% in early trading on Monday after a raft of upbeat ratings from brokerages lifted investor ...
The pharmaceutical industry faces policy volatility with new tariffs, MFN pricing, and marketing rule changes, impacting ...
USMNT and USWNT fans often complain about high ticket prices, repetitive cities and weak opponents for games, but U.S. Soccer ...
A late summer deal between the Trump administration and the European Union, for example, slapped a 15% duty on imported wines.
As the temperatures continue to plummet, we're all looking for comfy and cosy ways to keep our feet warm without sacrificing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results